Armenia vs Uruguay: Tuberculosis patients living with HIV receiving antiretroviral therapy
Armenia
62 patients
in 2019
Uruguay
52 patients
in 2021
Armenia rank
86th
Uruguay rank
88th
Tuberculosis patients living with HIV receiving antiretroviral therapy over time
- Armenia
- Uruguay
How they compare
Armenia currently reports 62 patients against 52 patients in Uruguay, a difference of 10 patients.
That makes Armenia's figure about 1.2 times Uruguay's.
The two have swapped places 4 times across 14 shared years of data; in 2006 it was Uruguay ahead.
Armenia ranks 86th and Uruguay ranks 88th of 183 countries.
Uruguay has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Armenia | Uruguay | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 5.5 patients | 20.5 patients | 15 patients | Uruguay |
| 2010s | 54.5 patients | 67 patients | 12.5 patients | Uruguay |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher tuberculosis patients living with hiv receiving antiretroviral therapy, Armenia or Uruguay?
- Armenia, at 62 patients against 52 patients in Uruguay as of 2019.
- What is the difference in tuberculosis patients living with hiv receiving antiretroviral therapy between Armenia and Uruguay?
- 10 patients, with Armenia ahead.
- How many years of comparable data are there for Armenia and Uruguay?
- 14 years are reported by both, from 2006 to 2019.
- How do Armenia and Uruguay rank globally for tuberculosis patients living with hiv receiving antiretroviral therapy?
- Armenia ranks 86th and Uruguay ranks 88th of 183 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026); Population based on various sources (2024) – with minor processing by Our World in Data, published as Tuberculosis patients living with HIV receiving antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of tuberculosis patients who are living with HIV and receiving antiretroviral therapy.